Open-label Safety Study in Adults With ADHD

PHASE3CompletedINTERVENTIONAL
Enrollment

724

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Adult Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Dasotraline

Dasotraline 4 mg, 6 mg, 8 mg, flexibly dosed, once daily

Trial Locations (65)

10003

Village Clinical Research Inc., New York

10016

NYU School of Medicine, New York

10023

Medical & Behavioral Health Research, New York

10128

The Medical Research Network, LLC, New York

10168

Fieve Clinical Research, New York

10305

Woodhull Medical & Mental Health Center, Staten Island

10312

Richmond Behavioral Associates, Staten Island

10549

Bioscience Research, Mount Kisco

19063

Suburban Research Associates, Media

19380

Sleep Diagnosists and Treatment Centers, West Chester

19403

Keystone Clinical Studies, LLC, Norristown

20170

NeuroScience, Inc, Herndon

21205

Kennedy Krieger Institute, Baltimore

27705

Duke University Medical Center, Durham

29464

Coastal Carolina Research Center, Mt. Pleasant

30005

Institute for Advanced Medical Research, Alpharetta

30030

iResearch Atlanta, LLC, Decatur

30080

Carman Research, Smyrna

30308

Atlanta Center for Medical Research, Atlanta

32256

Clinical Neuroscience Solutions, Inc., Jacksonville

32350

Geroge M. Joseph MD, PA, Jacksonville Beach

Midwest Clinical Research Center, Dayton

32751

Florida Clinical Research Center, LLC, Maitland

32801

Clinical Neuroscience Solutions, Inc, Orlando

32901

Acumentality, Melbourne

33026

Broward Research Group, Inc., Hollywood

33613

Stedman Clinical Trials, Tampa

33912

Gulfcoast Clinical Research, Fort Myers

34208

Florida Clinical Research Center LLC, Bradenton

34748

Compass Research North, LLC, Leesburg

38119

Clinical Neuroscience Solutions, Memphis

Research Strategies of Memphis, LLC, Memphis

44718

Neuro-Behavioral Clinical Research, Canton

46260

Goldpoint Clinical Research, Indianapolis

47905

Alpine Clinic, Lafayette

48307

Rochester Center for Behavioral Medicine, Rochester Hills

53562

Dean Foundation, Middleton

Eastside Therapeutic Resource, Middleton

63304

Midwest Research Group, Saint Charles

63368

Psychiatric Care & Research Center, O'Fallon

68526

Premeir Psychiatric Research Institute, LLC, Lincoln

70601

Lake Charles Clinical Trials LLC, Lake Charles

73103

IPS Research Company, Oklahoma City

73116

Cutting Edge Research Group, Oklahoma City

75231

FutureSearch Trials of Dallas, LP, Dallas

75243

Pillar Clinical Research, LLC, Dallas

77098

Houston Clinical Trials, LLC, Houston

77381

Family Psychiatry of the Woodlands, The Woodlands

78229

Clinical Trials of Texas, Inc, San Antonio

80910

MCB Clinical Research Centers, LLC, Colorado Springs

89128

Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas

90210

Southern California Research LLC, Beverly Hills

90720

Pharmacology Research Institute, Los Alamitos

Psychiatric Associates, Overland Park

91316

Pharmacology Research Institute, Encino

92025

Synergy Clinical Research of Escondido, Escondido

92056

Excell Research, Inc, Oceanside

92103

Artemis Institute for Clinical Research, San Diego

92845

Collaborative Neuroscience Network, LLC, Garden Grove

97210

Summit Research Network, Portland

97214

Oregon Center for Clinical Investigations, Inc., Portland

98104

Summit Research Network (Seattle) LLC, Seattle

02114

Massachusetts General Hospital, Boston

08002

Center for Emotional Fitness, Cherry Hill

05091

Neuropsychiatric Associates, Woodstock

All Listed Sponsors
lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT02160262 - Open-label Safety Study in Adults With ADHD | Biotech Hunter | Biotech Hunter